Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Larimar Therapeutics, Inc. LRMR NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$12.00
+148.4%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Larimar Therapeutics, Inc. (LRMR), dont 47 achats et 0 ventes. Le total des achats d'initiés s'élève à $34.99M et le total des ventes d'initiés à RSU Award.

Les initiés notables ayant une activité récente comprennent Sherman Jeffrey W, Thomas Frank E, Flynn James E. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — LRMR

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-02-27 Sherman Jeffrey W Director Achat Informatif 5,000 $5.00 $25K 5,000
2026-02-27 Thomas Frank E Director Achat Informatif 5,000 $5.00 $25K 7,000
2026-02-27 Flynn James E 10 Percent Owner, Other: * Director By Deputization Achat Informatif 2,000,000 $5.00 $10M 6,207,982
2026-02-27 Hamilton Thomas Edward Director Achat Informatif 100,000 $5.00 $500K 664,798
2026-01-26 Celano Michael Chief Financial Officer Attribution de RSU 37,604 - - 215,785
2026-01-26 Ben-maimon Carole President and CEO Attribution de RSU 100,100 - - 368,276
2026-01-26 Clayton Russell Chief Medical Officer Attribution de RSU 25,637 - - 71,443
2026-01-26 Shankar Gopi Chief Development Officer Attribution de RSU 25,637 - - 76,443
2025-07-31 Flynn James E 10 Percent Owner, Other: * Director By Deputization Achat Informatif 2,599,932 $3.20 $8.32M 7,321,129
2025-05-13 Leff Jonathan S Director Attribution de RSU 19,000 $1.88 $35.63K 19,000
2025-05-13 Sherman Jeffrey W Director Attribution de RSU 19,000 $1.88 $35.63K 19,000
2025-05-13 Thomas Frank E Director Attribution de RSU 19,000 $1.88 $35.63K 19,000
2025-05-13 Truitt Joseph Director Attribution de RSU 19,000 $1.88 $35.63K 19,000
2025-05-13 Hamilton Thomas Edward Director Attribution de RSU 19,000 $1.88 $35.63K 19,000
2025-05-13 Flynn James E 10 Percent Owner, Other: * Director By Deputization Attribution de RSU 19,000 $1.88 $35.63K 19,000
2025-01-22 Celano Michael Chief Financial Officer Attribution de RSU 34,185 - - 178,181
2025-01-22 Ben-maimon Carole President and CEO Attribution de RSU 91,000 - - 387,208
2025-01-22 Clayton Russell Chief Medical Officer Attribution de RSU 23,306 - - 45,806
2025-01-22 Shankar Gopi Chief Development Officer Attribution de RSU 23,306 - - 50,806
2024-05-29 Leff Jonathan S Director Attribution de RSU 19,000 $7.07 $134.33K 19,000
2024-05-29 Sherman Jeffrey W Director Attribution de RSU 19,000 $7.07 $134.33K 19,000
2024-05-29 Thomas Frank E Director Attribution de RSU 19,000 $7.07 $134.33K 19,000
2024-05-29 Truitt Joseph Director Attribution de RSU 19,000 $7.07 $134.33K 19,000
2024-05-29 Hamilton Thomas Edward Director Attribution de RSU 19,000 $7.07 $134.33K 19,000
2024-05-29 Flynn James E 10 Percent Owner, Other: * Director By Deputization Attribution de RSU 19,000 $7.07 $134.33K 19,000
2024-02-16 Flynn James E 10 Percent Owner, Other: * Director By Deputization Achat Informatif 1,430,205 $8.74 $12.5M 4,207,982
2024-02-16 Hamilton Thomas Edward Director Achat Informatif 57,208 $8.74 $500K 564,798
2024-02-14 Thomas Frank E Director Achat Informatif 2,000 $11.00 $22K 2,000
2024-01-17 Celano Michael Chief Financial Officer Attribution de RSU 31,250 - - 143,996
2024-01-17 Ben-maimon Carole President and CEO Attribution de RSU 66,125 - - 332,954
2024-01-17 Clayton Russell Chief Medical Officer Attribution de RSU 22,500 - - 22,500
2024-01-17 Shankar Gopi Chief Development Officer Attribution de RSU 22,500 - - 27,500
2023-12-07 Shankar Gopi Chief Development Officer Achat Informatif 5,000 $3.73 $18.66K 5,000
2023-10-03 Sherman Jeffrey W Director Inconnu - - - -
2023-10-03 Sherman Jeffrey W Director Attribution de RSU 16,600 $3.56 $59.01K 16,600
2023-07-17 Clayton Russell Officer Inconnu - - - -
2023-07-17 Clayton Russell Chief Medical Officer Attribution de RSU 180,000 $3.22 $579.6K 180,000
2023-05-17 Celano Michael Chief Financial Officer Achat Informatif 5,000 $3.73 $18.63K 112,746
2023-05-17 Truitt Joseph Director Achat Informatif 2,750 $3.73 $10.26K 2,750
2023-05-17 Ben-maimon Carole President and CEO Achat Informatif 5,000 $3.71 $18.53K 266,829
2023-05-09 Leff Jonathan S Director Attribution de RSU 8,300 $5.09 $42.25K 8,300
2023-05-09 Thomas Frank E Director Attribution de RSU 8,300 $5.09 $42.25K 8,300
2023-05-09 Flynn James E 10 Percent Owner Attribution de RSU 8,300 $5.09 $42.25K 8,300
2023-05-09 Truitt Joseph Director Attribution de RSU 8,300 $5.09 $42.25K 8,300
2023-05-09 Hamilton Thomas Edward Director Attribution de RSU 8,300 $5.09 $42.25K 8,300
2023-02-07 Shankar Gopi Officer Inconnu - - - -
2023-02-07 Shankar Gopi Chief Development Officer Attribution de RSU 180,000 $5.88 $1.06M 180,000
2023-01-31 Celano Michael Chief Financial Officer Attribution de RSU 76,000 - - 107,746
2023-01-31 Ben-maimon Carole President and CEO Attribution de RSU 205,000 - - 261,829
2022-09-16 Celano Michael Chief Financial Officer Achat Informatif 31,746 $3.15 $100K 31,746
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message